HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.

Abstract
In the present study, a comparative evaluation of the effects of calcium acetate, calcium carbonate, sevelamer hydrochloride and lanthanum carbonate was carried out in 120 patients with end stage kidney disease (ESKD) undergoing hemodialysis. Biochemical parameters, like serum phosphorous, serum calcium and serum alkaline phosphatase level and intact parathyroid hormone level, were measured. A statistically significant reduction in serum phosphorous, serum calcium, calcium × phosphorous and serum alkaline phosphatase level were observed with all phosphate binders during 3 months of treatment. Reduction in serum phosphorous were observed with calcium acetate (1.5 mg/dL), calcium carbonate (1.3 mg/dL), sevelamer hydrochloride (2.1 mg/dL) and lanthanum carbonate (1.79 mg/dL). The reduction of serum alkaline phosphatase was observed more commonly with sevelamer (107.37 IU/L) and lanthanum (104.33 IU/L) treatments than with calcium acetate (93.9 IU/L) and calcium carbonate (86.57 IU/L). There was no statistically significant change in serum calcium observed with sevelamer and lanthanum treatments, while calcium-based phosphate binders caused a significant rise in the serum calcium level. Serum intact parathyroid hormone level was significantly reduced with all phosphate binder treatments. This decline was highest with sevelamer and lowest with calcium carbonate. All treatments were well tolerated and safety profiles were consistent with previous reports in hemodialysis patients. It is concluded that all phosphate binders are safe and effective for the treatment of hyperphosphatemia in patients with ESKD undergoing hemodialysis. However, sevelamer hydrochloride seems to be superior among all with lowering incidence of hypercalcemia.
AuthorsViken A Prajapati, Varsha J Galani, Pankaj R Shah
JournalSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia (Saudi J Kidney Dis Transpl) Vol. 25 Issue 3 Pg. 530-8 (May 2014) ISSN: 1319-2442 [Print] Saudi Arabia
PMID24821148 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Acetates
  • Biomarkers
  • Calcium Compounds
  • Chelating Agents
  • Polyamines
  • Phosphorus
  • lanthanum carbonate
  • Lanthanum
  • Sevelamer
  • Calcium Carbonate
  • Calcium
  • calcium acetate
Topics
  • Acetates (therapeutic use)
  • Adult
  • Biomarkers (blood)
  • Calcium (blood)
  • Calcium Carbonate (therapeutic use)
  • Calcium Compounds (therapeutic use)
  • Chelating Agents (adverse effects, therapeutic use)
  • Female
  • Humans
  • Hypercalcemia (blood, drug therapy)
  • Hyperphosphatemia (blood, diagnosis, drug therapy)
  • Kidney Failure, Chronic (blood, diagnosis, therapy)
  • Lanthanum (therapeutic use)
  • Male
  • Middle Aged
  • Phosphorus (blood)
  • Polyamines (therapeutic use)
  • Renal Dialysis
  • Retrospective Studies
  • Sevelamer
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: